News

Link Pharma Chem Limited will close its trading window for securities from October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s code of conduct, remaining closed until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, with the board meeting date to be announced later.

Link Pharma Chem will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Link Pharma Chem announced that the Annual General Meeting(AGM) of the company will be held on 20 August 2026.

Net Loss of Link Pharma Chem reported to Rs 0.41 crore in the quarter ended March 2026 as against net loss of Rs 0.35 crore during the previous quarter ended March 2025. Sales rose 2.17% to Rs 6.59 crore in the quarter ended March 2026 as against Rs 6.45 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.08 crore in the year ended March 2026 as against net loss of Rs 1.03 crore during the previous year ended March 2025. Sales rose 7.86% to Rs 27.43 crore in the year ended March 2026 as against Rs 25.43 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.596.45 2 27.4325.43 8 OPM %-3.64-3.41 -5.290.51 - PBDT-0.24-0.24 0 1.12-0.46 LP PBT-0.49-0.48 -2 0.14-1.40 LP NP-0.41-0.35 -17 0.08-1.03 LP Powered by Capital Market - Live News

Link Pharma Chem will hold a meeting of the Board of Directors of the Company on 21 May 2026.